BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21567470)

  • 1. Rapid estimation of whole blood everolimus concentrations using architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry.
    Dasgupta A; Moreno V; Balark S; Smith A; Sonilal M; Tejpal N; Van Buren CT
    J Clin Lab Anal; 2011; 25(3):207-11. PubMed ID: 21567470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A; Davis B; Chow L
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy evaluation of automated electrochemiluminescence immunoassay for everolimus and sirolimus compared to liquid chromatography-tandem mass spectrometry.
    Lee EJ; Kim HK; Ahn S; Lee W; Kim HS; Chun S; Min WK
    J Clin Lab Anal; 2019 Sep; 33(7):e22941. PubMed ID: 31197901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
    Morgan PE; Brown NW; Tredger JM
    Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
    Hermida-Cadahia EF; Tutor JC
    Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latex-enhanced turbidimetric immunoassay for everolimus in whole blood using the Nanopia TDM everolimus assay with the JCA-BM6010 automatic analyzer.
    Mori K; Kimura S; Matsui M; Suehisa E; Hidaka Y; Fukushima N
    Ther Drug Monit; 2014 Oct; 36(5):677-80. PubMed ID: 25222856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
    Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
    Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.
    Karapirli M; Kizilgun M; Yesilyurt O; Gul H; Kunak ZI; Akgul EO; Macit E; Cayci T; Gulcan Kurt Y; Aydin I; Yaren H; Seyrek M; Cakir E; Yaman H
    ScientificWorldJournal; 2012; 2012():571201. PubMed ID: 22629148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
    Heideloff C; Payto D; Wang S
    Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.
    Mueller DM; Rentsch KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1007-12. PubMed ID: 20308022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.
    Capone D; Cataldi M; Guida B; Mosca T; Tarantino G
    Scand J Clin Lab Invest; 2018 Jul; 78(4):275-280. PubMed ID: 29575933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.